Company: GSRF
Filing Date: 2025-06-20
Form Type: DRS
Source: 0001213900-25-056174
Chunk: 302

Company: GSR IV Acquisition Corp.
Filing Date: 2025-06-20
Form: DRS
Chunk 302
---
 statements.

F-4 Confidential Treatment Requested by GSR IV Acquisition Corp.
Pursuant to 17 C.F.R. Section 200.83

GSR IV ACQUISITION CORP.
STATEMENTS OF CHANGES IN SHAREHOLDER’S (DEFICIT) EQUITY
FOR THE THREE MONTHS ENDED MARCH 31, 2025 (Unaudited)

|                           |     | Class A         
 Ordinary Shares 
 Shares          |     | Amount |   |     |         Class B 
 Ordinary Shares 
          Shares |     | Amount |     |     | Additional 
 Paid-in    
 Capital    |        |     | Accumulated 
 Deficit     |         |   |     | Total         
 Shareholder’s 
 Deficit       |        |   |
|:--------------------------|:----|:----------------|:----|:-------|:--|:----|----------------:|:----|:-------|----:|:----|:-----------|-------:|:----|:------------|:--------|:--|:----|:--------------|:-------|:--|
| Balance – January 1, 2025 |     | —               |     | $      | — |     |       5,750,000 |     | $      | 575 |     | $          | 24,425 |     | $           | (25,933 | ) |     | $             | (933   | ) |
| Net loss                  |     | —               |     |        | — |     |               — |     |        |   — |     |            |      — |     |             | (2,867  | ) |     |               | (2,867 | ) |
| Balance – March 31, 2025  |     | —               |     | $      | — |     |       5,750,000 |     | $      | 575 |     | $          | 24,425 |     | $           | (28,800 | ) |     | $             | (3,800 | ) |

The accompanying notes are an integral part of these financial statements.

F-5 Confidential Treatment Requested by GSR IV Acquisition Corp.
Pursuant to 17 C.F.R. Section 200.83

GSR IV ACQUISITION CORP. STATEMENTS OF CHANGES IN SHAREHOLDER’S (DEFICIT) EQUITY — (Continued) FOR THE THREE